Exome Asset Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,917	Closed	-$250K	–	64
2024 Q4	$250K	Sell	6,917 -40,226	-85%	-$1.45M	0.19%	57
2024 Q3	$2.23M	Buy	+47,143	New	+$2.23M	1.51%	28